According to the Zhitong Finance APP, Landfar Bio-medicine (000504.SZ) released its annual performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company to be between 12.5 million and 15.5 million yuan, turning from a loss to a profit year-on-year.

Reasons for performance changes: 1. During the reporting period, with the improvement of the company's financial situation and capital structure, the company's financial costs decreased significantly compared to the previous year; 2. During the reporting period, through optimizing business management, the overall profitability of the company's cell business improved compared to last year; 3. During the reporting period, the company increased its income and profit sources by further strengthening the sales of self-operated beauty products and expanding the agency sales of other products in related fields